Cognition Model

We have the capabilities to conduct preclinical studies around the cognition model

What is the Cognition Model?

A cognitive model is an estimation of animal cognitive processes for the purposes of comprehension and prediction of factors.

Transpharmation has a vast understanding in preclinical cognition research obtained through decades of experience running disease area portfolios for Parkinson’s disease, Alzheimer’s disease and Schizophrenia within GlaxoSmithKline. Most importantly, our highly skilled technical staff appreciate the subtleties involved in evaluating rodent cognitive processes, ensuring all our assays are highly robust and reproducible, ensuring a respectable study is carried out.

We focus on delivering carefully selected cognition models which are disease-relevant thereby offering the option to evaluate NCEs against pharmacologically induced cognition impairments, (e.g scopolamine) or natural impairments, (age, test parametric manipulation) across multiple disease areas.

Cognition models we offer:

  • Novel object recognition
  • temporal deficit
  • pharmacological deficit, (scopolamine, sub-chronic PCP)
  • Delayed-non-match to position
  • Reversal learning
  • Attentional set shifting

cognition modelTo discuss your requirements further and get your project underway please do not hesitate to speak with us. We are always developing new areas of discovery within our preclinical field of expertise. If there is something particular that is not listed here please do contact us.

Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60

mail contact@transpharmation.co.uk


Copyright

Copyright © 2020 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design

IASP VIRTUAL SERIES ON PAIN & EXPO

The first International Association for the Study of Pain, (IASP) virtual conference is live!

Come and visit Transpharmation’s booth #iaspvirtualseries

View our latest specialist poster on pain; ‘The effect of a reduced streptozocin dose and social housing on well-being, mechanical hypersensitivity and burrowing behaviour in type 1 diabetic rodents’ and find out more about our wide-ranging pain expertise.  We look forward to seeing you there.

IASP Footer